Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic.
Identifieur interne : 000325 ( Main/Exploration ); précédent : 000324; suivant : 000326Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic.
Auteurs : Eakachai Prompetchara [Thaïlande] ; Chutitorn Ketloy [Thaïlande] ; Tanapat Palaga [Thaïlande]Source :
- Asian Pacific journal of allergy and immunology [ 0125-877X ] ; 2020.
Abstract
As the world is witnessing the epidemic of COVID-19, a disease caused by a novel coronavirus, SARS-CoV-2, emerging genetics and clinical evidences suggest a similar path to those of SARS and MERS. The rapid genomic sequencing and open access data, together with advanced vaccine technology, are expected to give us more knowledge on the pathogen itself, including the host immune response as well as the plan for therapeutic vaccines in the near future. This review aims to provide a comparative view among SARS-CoV, MERS-CoV and the newly epidemic SARS-CoV-2, in the hope to gain a better understanding of the host-pathogen interaction, host immune responses, and the pathogen immune evasion strategies. This predictive view may help in designing an immune intervention or preventive vaccine for COVID-19 in the near future.
DOI: 10.12932/AP-200220-0772
PubMed: 32105090
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000442
- to stream PubMed, to step Curation: 000442
- to stream PubMed, to step Checkpoint: 000301
- to stream Ncbi, to step Merge: 000969
- to stream Ncbi, to step Curation: 000969
- to stream Ncbi, to step Checkpoint: 000969
- to stream Main, to step Merge: 000327
- to stream Main, to step Curation: 000325
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic.</title><author><name sortKey="Prompetchara, Eakachai" sort="Prompetchara, Eakachai" uniqKey="Prompetchara E" first="Eakachai" last="Prompetchara">Eakachai Prompetchara</name><affiliation wicri:level="1"><nlm:affiliation>Center of Excellence in Vaccine Research and Development (Chula Vaccine Research Center Chula VRC), Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.</nlm:affiliation><country xml:lang="fr">Thaïlande</country><wicri:regionArea>Center of Excellence in Vaccine Research and Development (Chula Vaccine Research Center Chula VRC), Faculty of Medicine, Chulalongkorn University, Bangkok 10330</wicri:regionArea><wicri:noRegion>Bangkok 10330</wicri:noRegion></affiliation></author><author><name sortKey="Ketloy, Chutitorn" sort="Ketloy, Chutitorn" uniqKey="Ketloy C" first="Chutitorn" last="Ketloy">Chutitorn Ketloy</name><affiliation wicri:level="1"><nlm:affiliation>Center of Excellence in Vaccine Research and Development (Chula Vaccine Research Center Chula VRC), Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.</nlm:affiliation><country xml:lang="fr">Thaïlande</country><wicri:regionArea>Center of Excellence in Vaccine Research and Development (Chula Vaccine Research Center Chula VRC), Faculty of Medicine, Chulalongkorn University, Bangkok 10330</wicri:regionArea><wicri:noRegion>Bangkok 10330</wicri:noRegion></affiliation></author><author><name sortKey="Palaga, Tanapat" sort="Palaga, Tanapat" uniqKey="Palaga T" first="Tanapat" last="Palaga">Tanapat Palaga</name><affiliation wicri:level="1"><nlm:affiliation>Center of Excellence in Immunology and Immune-mediated Diseases, Chulalongkorn University, Bangkok 10330, Thailand.</nlm:affiliation><country xml:lang="fr">Thaïlande</country><wicri:regionArea>Center of Excellence in Immunology and Immune-mediated Diseases, Chulalongkorn University, Bangkok 10330</wicri:regionArea><wicri:noRegion>Bangkok 10330</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32105090</idno><idno type="pmid">32105090</idno><idno type="doi">10.12932/AP-200220-0772</idno><idno type="wicri:Area/PubMed/Corpus">000442</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000442</idno><idno type="wicri:Area/PubMed/Curation">000442</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000442</idno><idno type="wicri:Area/PubMed/Checkpoint">000301</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000301</idno><idno type="wicri:Area/Ncbi/Merge">000969</idno><idno type="wicri:Area/Ncbi/Curation">000969</idno><idno type="wicri:Area/Ncbi/Checkpoint">000969</idno><idno type="wicri:doubleKey">0125-877X:2020:Prompetchara E:immune:responses:in</idno><idno type="wicri:Area/Main/Merge">000327</idno><idno type="wicri:Area/Main/Curation">000325</idno><idno type="wicri:Area/Main/Exploration">000325</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic.</title><author><name sortKey="Prompetchara, Eakachai" sort="Prompetchara, Eakachai" uniqKey="Prompetchara E" first="Eakachai" last="Prompetchara">Eakachai Prompetchara</name><affiliation wicri:level="1"><nlm:affiliation>Center of Excellence in Vaccine Research and Development (Chula Vaccine Research Center Chula VRC), Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.</nlm:affiliation><country xml:lang="fr">Thaïlande</country><wicri:regionArea>Center of Excellence in Vaccine Research and Development (Chula Vaccine Research Center Chula VRC), Faculty of Medicine, Chulalongkorn University, Bangkok 10330</wicri:regionArea><wicri:noRegion>Bangkok 10330</wicri:noRegion></affiliation></author><author><name sortKey="Ketloy, Chutitorn" sort="Ketloy, Chutitorn" uniqKey="Ketloy C" first="Chutitorn" last="Ketloy">Chutitorn Ketloy</name><affiliation wicri:level="1"><nlm:affiliation>Center of Excellence in Vaccine Research and Development (Chula Vaccine Research Center Chula VRC), Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.</nlm:affiliation><country xml:lang="fr">Thaïlande</country><wicri:regionArea>Center of Excellence in Vaccine Research and Development (Chula Vaccine Research Center Chula VRC), Faculty of Medicine, Chulalongkorn University, Bangkok 10330</wicri:regionArea><wicri:noRegion>Bangkok 10330</wicri:noRegion></affiliation></author><author><name sortKey="Palaga, Tanapat" sort="Palaga, Tanapat" uniqKey="Palaga T" first="Tanapat" last="Palaga">Tanapat Palaga</name><affiliation wicri:level="1"><nlm:affiliation>Center of Excellence in Immunology and Immune-mediated Diseases, Chulalongkorn University, Bangkok 10330, Thailand.</nlm:affiliation><country xml:lang="fr">Thaïlande</country><wicri:regionArea>Center of Excellence in Immunology and Immune-mediated Diseases, Chulalongkorn University, Bangkok 10330</wicri:regionArea><wicri:noRegion>Bangkok 10330</wicri:noRegion></affiliation></author></analytic><series><title level="j">Asian Pacific journal of allergy and immunology</title><idno type="ISSN">0125-877X</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">As the world is witnessing the epidemic of COVID-19, a disease caused by a novel coronavirus, SARS-CoV-2, emerging genetics and clinical evidences suggest a similar path to those of SARS and MERS. The rapid genomic sequencing and open access data, together with advanced vaccine technology, are expected to give us more knowledge on the pathogen itself, including the host immune response as well as the plan for therapeutic vaccines in the near future. This review aims to provide a comparative view among SARS-CoV, MERS-CoV and the newly epidemic SARS-CoV-2, in the hope to gain a better understanding of the host-pathogen interaction, host immune responses, and the pathogen immune evasion strategies. This predictive view may help in designing an immune intervention or preventive vaccine for COVID-19 in the near future.</div></front></TEI><affiliations><list><country><li>Thaïlande</li></country></list><tree><country name="Thaïlande"><noRegion><name sortKey="Prompetchara, Eakachai" sort="Prompetchara, Eakachai" uniqKey="Prompetchara E" first="Eakachai" last="Prompetchara">Eakachai Prompetchara</name></noRegion><name sortKey="Ketloy, Chutitorn" sort="Ketloy, Chutitorn" uniqKey="Ketloy C" first="Chutitorn" last="Ketloy">Chutitorn Ketloy</name><name sortKey="Palaga, Tanapat" sort="Palaga, Tanapat" uniqKey="Palaga T" first="Tanapat" last="Palaga">Tanapat Palaga</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000325 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000325 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32105090
|texte= Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32105090" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidV1
| This area was generated with Dilib version V0.6.33. |  |